Healthcare Sector
Market Tracker
BMY (Selected)
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 11/18/2022 | PUT | $45.00 | 5,136 | +4,982 | +3,235.06% |
| 08/19/2022 | PUT | $65.00 | 1,621 | +957 | +144.13% |
| 07/15/2022 | CALL | $80.00 | 23,840 | +767 | +3.32% |
| 08/19/2022 | PUT | $70.00 | 1,807 | +665 | +58.23% |
| 09/16/2022 | PUT | $50.00 | 619 | +491 | +383.59% |
| 08/19/2022 | PUT | $75.00 | 1,671 | +469 | +39.02% |
| 09/16/2022 | CALL | $85.00 | 5,313 | +445 | +9.14% |
| 07/29/2022 | CALL | $78.00 | 1,762 | +443 | +33.59% |
| 09/16/2022 | PUT | $70.00 | 3,910 | +392 | +11.14% |
| 07/01/2022 | CALL | $78.00 | 2,802 | +309 | +12.39% |
| 09/16/2022 | PUT | $75.00 | 4,306 | -745 | -14.75% |
| 09/16/2022 | CALL | $75.00 | 7,549 | -311 | -3.96% |
| 07/08/2022 | PUT | $77.00 | 4,850 | -278 | -5.42% |
| 07/15/2022 | PUT | $75.00 | 8,904 | -228 | -2.50% |
| 09/16/2022 | PUT | $77.50 | 3,968 | -227 | -5.41% |
| 07/15/2022 | CALL | $67.50 | 163 | -178 | -52.20% |
| 07/01/2022 | PUT | $78.00 | 250 | -135 | -35.06% |
| 07/22/2022 | CALL | $75.00 | 101 | -112 | -52.58% |
| 07/01/2022 | CALL | $80.00 | 1,196 | -52 | -4.17% |
| 07/15/2022 | CALL | $77.00 | 1,966 | -39 | -1.95% |
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.96% | 62.93M | 4.93B |
| Vanguard 500 Index Fund | 2.24% | 47.7M | 3.73B |
| Vanguard Specialized-Health Care Fund | 1.38% | 29.3M | 2.29B |
| SPDR S&P 500 ETF Trust | 1.11% | 23.63M | 1.85B |
| Fidelity 500 Index Fund | 1.07% | 22.81M | 1.79B |
| iShares Core S&P 500 ETF | 0.88% | 18.76M | 1.47B |
| Vanguard Index-Value Index Fund | 0.85% | 18.08M | 1.42B |
| Dodge & Cox Stock Fund | 0.82% | 17.52M | 1.37B |
| Select Sector SPDR Fund-Health Care | 0.80% | 17.12M | 1.34B |
| JP Morgan Equity Income Fund | 0.78% | 16.6M | 1.3B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.77% | 16.34M | 1.28B |
Black patients were rarely included in clinical trials — until the COVID-19 vaccines. What happens next?
07/01 07:31 am
MarketWatch
Read more3 Beaten-Down Growth Stocks to Buy Now and Hold Forever
07/01 07:15 am
The Motley Fool
Read moreAttention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
07/01 05:26 am
Benzinga
Read moreBristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know
06/29 05:50 pm
Zacks Investment Research
Read more3 Healthcare Giants Bucking The Bear Market
06/29 08:09 am
Investing.com
Read moreHere’s one sector that offers ‘offense, defense, growth and value’
06/28 07:15 pm
Invezz
Read moreSutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration
06/28 12:25 pm
Zacks Investment Research
Read moreBristol Myers (BMY) Breyanzi Gets FDA Nod for Label Expansion
06/27 01:06 pm
Zacks Investment Research
Read moreThe 2 Best Sectors to Invest in Right Now
06/27 05:55 am
The Motley Fool
Read moreBristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
06/23 05:45 pm
Zacks Investment Research
Read more3 Dirt Cheap Dividend Stocks to Buy Hand Over Fist
06/23 11:15 am
The Motley Fool
Read moreBristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know
06/22 05:50 pm
Zacks Investment Research
Read moreIovance (IOVA) Pipeline Aids Growth Amid Lack of Marketed Drugs
06/22 10:48 am
Zacks Investment Research
Read moreShould Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?
06/22 06:20 am
Zacks Investment Research
Read moreBristol Myers' (BMY) Breyanzi sBLA Receives EMA Validation
06/21 10:32 am
Zacks Investment Research
Read moreMereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout
06/20 10:36 am
Zacks Investment Research
Read moreSeven reasons the beleaguered biotech sector is now a 'buy'
06/18 07:33 am
MarketWatch
Read moreExelixis (EXEL), BioInvent Tie Up for Immuno-Oncology Therapies
06/17 11:31 am
Zacks Investment Research
Read moreU.S. companies are still making billions of dollars in adjustments so that their earnings look better, study finds
06/17 07:33 am
MarketWatch
Read more5 Stocks Warren Buffett Has Aggressively Sold Since 2022 Began
06/17 05:06 am
The Motley Fool
Read moreBristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know
06/16 05:45 pm
Zacks Investment Research
Read more2 Cheap Stocks to Buy Right Now
06/16 11:30 am
The Motley Fool
Read moreBristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
06/15 05:50 pm
Zacks Investment Research
Read moreCisco And 2 Other Stocks Insiders Are Selling
06/15 08:26 am
Benzinga
Read moreMorphoSys (MOR) Gains on Oncology Collaboration With Pfizer
06/14 11:00 am
Zacks Investment Research
Read moreBristol Myers (BMY) Up 20.4% YTD: Will the Momentum Continue?
06/13 09:52 am
Zacks Investment Research
Read moreShould You Invest in the VanEck Pharmaceutical ETF (PPH)?
06/13 06:20 am
Zacks Investment Research
Read moreASCO 2022: Surprising News in Cancer Research
06/10 05:00 pm
The Motley Fool
Read moreBristol Myers Squibb (BMY) Stock Moves -0.26%: What You Should Know
06/09 05:45 pm
Zacks Investment Research
Read moreRoche (RHHBY) Gets EU Nod for Lunsumio, Tecentriq Label Expansion
06/09 11:35 am
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights Bristol Myers, Turning Point Therapeutics, Regeneron, Novavax, and Mirati Therapeutics
06/09 10:43 am
Zacks Investment Research
Read moreBristol Myers Squibb (BMY) Stock Moves -0.54%: What You Should Know
06/08 05:50 pm
Zacks Investment Research
Read moreBiotech Stock Roundup: BMY's Acquisition, REGN to Buy Libtayo & More
06/08 01:20 pm
Zacks Investment Research
Read moreWhy Is Amicus Therapeutics (FOLD) Up 25.1% Since Last Earnings Report?
06/08 11:30 am
Zacks Investment Research
Read moreBristol Myers (BMY) to Acquire Turning Point, Withdraws sBLA
06/06 01:24 pm
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For June 6, 2022
06/06 11:12 am
Benzinga
Read more100 Billion Reasons to Like This Dominant Healthcare Stock
06/06 07:00 am
The Motley Fool
Read moreTracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 Update
06/06 12:49 am
Seeking Alpha
Read moreCan the Best-Selling Drugs of 2021 Repeat Their Performance?
06/05 05:43 am
The Motley Fool
Read moreBMY, IMTX Extend Deal to Develop Cell Therapies for Cancer
06/03 03:54 pm
Zacks Investment Research
Read moreRegeneron (REGN) to Buy Sanofi's Stake in Libtayo, Stock Down
06/03 03:42 pm
Zacks Investment Research
Read moreWhat 7 Analyst Ratings Have To Say About Bristol-Myers Squibb
06/03 01:22 pm
Benzinga
Read moreDow slumps 300 points as stocks turn lower for week after strong May jobs report
06/03 12:11 pm
MarketWatch
Read moreIs This Dividend Stock a Buy for Income Investors?
06/03 10:15 am
The Motley Fool
Read moreWhy Pfizer Needs a High-Growth Pipeline
06/03 07:54 am
The Motley Fool
Read moreBristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
06/02 05:45 pm
Zacks Investment Research
Read moreStocks Sink As Rates And The U.S. Dollar Surge
06/02 01:09 am
Investing.com
Read moreBiotech Stock Roundup: BMY's Opdivo Updates, Pipeline Updates From REGN, BIIB
06/01 02:39 pm
Zacks Investment Research
Read moreGot $5,000? Buy These 2 High-Growth Stocks Before They Soar
06/01 10:53 am
The Motley Fool
Read moreDon't fall in love with stocks, they'll break your heart
05/31 10:10 am
MarketWatch
Read moreJump to another section of the site or filter your current view by ticker symbol.
Quick search from anywhere using shortcuts